Literature DB >> 28449374

Genetic Variability in Adenosine Deaminase-Like Contributes to Variation in Alcohol Preference in Mice.

Heidi M B Lesscher1, Alexis Bailey2, Louk J M J Vanderschuren1.   

Abstract

BACKGROUND: A substantial part of the risk for alcohol use disorder is determined by genetic factors. We previously used chromosome substitution (CSS) mice, to identify a quantitative trait loci (QTL) for alcohol preference on mouse chromosome 2. The aim of this study was to identify candidate genes within this QTL that confer the risk for alcohol preference.
METHODS: In order to delineate the neurobiological underpinnings of alcohol consumption, we expanded on the QTL approach to identify candidate genes for high alcohol preference in mice. We narrowed down a QTL for alcohol preference on mouse chromosome 2, that we previously identified using CSS mice, to 4 candidate genes in silico. Expression levels of these candidate genes in prefrontal cortex, amygdala, and nucleus accumbens-brain regions implicated in reward and addiction-were subsequently compared for the CSS-2 and the C57BL/6J host strain.
RESULTS: We observed increased expression of adenosine deaminase-like (Adal) in all 3 regions in CSS-2 mice. Moreover, we found that the adenosine deaminase inhibitor EHNA reduced the difference in alcohol preference between CSS-2 and C57BL/6J mice.
CONCLUSIONS: This study identifies Adal as a genetically protective factor against alcohol consumption in mice, in which elevated Adal levels contribute to low alcohol preference.
Copyright © 2017 by the Research Society on Alcoholism.

Entities:  

Keywords:  Adenosine; Alcohol; Mice; Preference; Quantitative Trait Loci

Mesh:

Substances:

Year:  2017        PMID: 28449374     DOI: 10.1111/acer.13409

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  1 in total

1.  Overview of inactivating mutations in the protein-coding genome of the mouse reference strain C57BL/6J.

Authors:  Steven Timmermans; Claude Libert
Journal:  JCI Insight       Date:  2018-07-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.